1098.1 - Review of Interim Funded Service: Breast MRI

Page last updated: 18 July 2016

Application Detail



Description of Medical Service

MRI uses a strong external magnetic field to produce images of biological tissues. As breast tissue generally has similar signal intensity to tumour tissue on routine MRI, the intravenous administration of a contrast agent containing gadolinium chelate is used to enhance breast lesions. During the examination the patient lies prone on the MRI table with the breast dependant in the dedicated breast coil. A number of imaging sequences are obtained, prior to the administration of the contrast agent gadolinium. The MRI sequences obtained are interpreted by a radiologist to analyse the findings on the various sequences, including enhancement patterns. The aim is to distinguish between normal, benign and malignant findings. MRI can be used in both screening and diagnosis of breast cancer. This includes the identification of breast cancer in women with a high risk of breast cancer due to family history or genetic predisposition. Breast MRI is also used in preoperative staging, evaluating response to treatment, screening of women with breast augmentation or reconstruction and identification of occult breast cancer in women with metastatic disease.

Description of Medical Condition

Breast cancer in asymptomatic women with a high risk of developing breast cancer.

Reason for Application


Medical Service Type


Previous Application Number


Associated Documentation

Application Form


PICO Confirmation

Final Protocol (PDF 692 KB)
Final Protocol (Word 407 KB)

Assessment Report

Contracted Assessment Report (PDF 1514 KB)
Contracted Assessment Report (Word 1002 KB)

Public Summary Document

Public Summary Document (PDF 436 KB)
Public Summary Document (Word 77 KB)

Meetings for this Application


1 to 2 December 2011


13 to 14 February 2014


3 to 4 April 2014